Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (DRKS00040128) titled 'Change in peritumoral functional network connectedness under Optune therapy in glioblastoma: a longitudinal, matched pilot study' on Oct. 9.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: Prognosis
Primary Sponsor: Universitatsmedizin Mannheim
Condition:
Glioblastoma
C71
Malignant neoplasm of brain
Intervention:
Group 1: Patients with Glioblastoma under Optune-Therapy. Addition of an extra resting-state fMRI sequence during scheduled clinical follow-up MRI scans.
Recruitment Status: Not Recruiting
Date of First Enrollment: 01/11/2026
Target Sample ...